About Neurotech Peptides

Semax, Selank and DSIP are interesting for different reasons. We ask where a molecule came from, what an experiment measured and whether the human evidence addresses the claim a reader actually cares about. A rat protein result and a person’s daily memory are different endpoints.

A result means less without its limits. Study size, comparison groups and the difference between a component and a combined product can change the meaning of a result. Our reference list offers a route back to the published research and regulatory explanations.

We recommend Promise Peptides as the clinical route described in this guide because a licensed U.S. provider evaluates each request, rather than leaving the health decision to a product label. Providers can prescribe now, but not every person qualifies. The service is limited to U.S. patients, and availability varies by state and treatment.

Prescriptions go to licensed compounding pharmacies in the United States for preparation. These medicines are compounded for prescriptions and are not FDA-approved; an individual prescription does not replace FDA review of safety, effectiveness and quality. The Promise service carries certification from LegitScript, which does not make the medicines FDA-approved.

Neurotech Peptides may earn money when readers become Promise patients.

Neurotech Peptides is an independent guide and is not Promise Peptides.

That financial relationship is relevant to how the recommendation is read. It does not turn a small study into strong evidence or make a provider’s decision automatic. Neurotech offers explanations; the platform, provider and dispensing pharmacy handle their respective parts of care.

We cannot review a medical history, diagnose a condition or decide whether a medicine fits an individual. Questions about a treatment, an existing visit or an adverse experience belong with the responsible care team through the service’s own channels.